Several functional properties have been attributed to soy protein hydrolysates (SPHs); however, their gut fermentation needs to be investigated. This study aimed to determine the effect of hypo-allergic pepsineduced SPH on the growth of gut microbiota, SCFA and BCFA production in a pH-controlled, stirred, batch culture fermentation system compared with commercial SPH and soy protein isolate (SPI). The results showed that all substrates affected gut bacteria. SPH selectively increased the number of lactobacilli (log 9.61 to log 9.84) at 72-h fermentation, but not for bifidobacteria. This is in accordance with increased BCFAs yield of 15.54 AE 0.00 mM (isobutyrate) and 465.59 AE 1.42 mM (isovalerate). The gut microbial balance index (GMBI) of SPH was 0.23, thus suggesting its gut microbial modulation. Therefore, SPH has potential for modulation or balance of gut microbiota, which may be used as functional ingredient for emerging market of nutraceuticals and nutri-pharmaceutical industry.
Introduction
The human gut consists of approximately 10 14 bacterial cells per gram of luminal content (Qin et al., 2010) , belonging to thousands of bacterial taxa (Wylie et al., 2012) . This population, also known as the gut microbiota, metabolically affects the physiological, nutritional and health status of the host (Tremaroli & B€ ackhed, 2012) , such as immunomodulation of the host's mucosa, luminal metabolism of undigested/partially digested alimentary compounds, micronutrients, vitamin synthesis and resistance (Laparra & Sanz, 2010) . Prebiotics of carbohydrates origin are commonly used to enhance or modulate the gut microbiota (Koh et al., 2016; Wichienchot et al., 2016 Wichienchot et al., , 2017 , but nondigestible proteins and bioactive peptides may also prove beneficial. Unabsorbed carbohydrates, which include fibres and resistant starch, are the dietary substrates for short-chain fatty acids (SCFAs) production (Laparra & Sanz, 2010) by microbial fermentation in the gut. SCFAs are volatile and straight chained; however, branched-chain fatty acids (BCFAs) are also produced when proteins are present as the only available carbon source (Neis et al., 2015) .
Bioactive peptides having potential immunomodulatory and physiological health benefits are formed when proteins are broken down by proteases and peptidases in the gastrointestinal tract. The biological and immunomodulatory activities of some enzymatically prepared peptides/hydrolysates using in vitro models have been studied, with profound outcomes (Majumder et al., 2015; Marques et al., 2015) . However, the disposition of the gut microbiome towards the often readily available substrates of nitrogen, carbon and energy from protein sources ingested into the gastrointestinal tract has been rarely studied.
Diets high in animal protein, fats, eggs, alcohol and sulphur have been shown to increase pathogenic microbial populations and their metabolites in the large intestine (Roberfroid et al., 2010) . Nevertheless, soy protein hydrolysates (SPHs) have been reported to exhibit various physiological activities that include hypolipidemic and hypocholesterolemic properties (Wanezaki et al., 2015) , antioxidant activity (Ranamukhaarachchi et al., 2017) , anti-allergic effect , insulin resistance (Phillips et al., 2016) , anti-inflammatory and anti-cancer property (Li-Chan, 2015) and immunomodulatory activity . This is due to the modified secondary or tertiary structures in the hydrolysates, which increase their rate of absorption in the small intestine. Yet not all the hydrolysates are absorbable, and until now, simulated in vitro fermentative activity of nondigestible soy protein hydrolysates prepared with one or several proteases has not been investigated. Therefore, this study aimed to determine the effect of digested pepsin-educed soy protein hydrolysates on the growth of gut microbiota in a pH-controlled, stirred, batch culture fermentation system, compared with commercial SPH and soy protein isolate (SPI). Protein fermentation end products, that is BCFAs were also determined as metabolically produced by the gut microbiota from the nondigestible soy protein and its hydrolysates.
Materials and methods

Materials
Food grade soy protein isolate [SPI (protein content 90.2% dry base)] was purchased from Wachsen Industry Company, Ltd (Qingdao, China). Pepsin (250 l mg
À1
) was purchased from Sigma Co. (St. Louis, MO, USA). Commercial hydrolysed soy protein was purchased from Hangzhou New Asia International Company, Ltd (Zhejiang, China). DNA probes used for FISH technique were purchased from SigmaAldrich (Bif164, Lab158, Bac303, Chris150 and Eub338). All other chemicals used were analytical grade.
Preparation of pepsin-educed soy protein hydrolysate SPI was dissolved in deionised water in a ratio of 1:8 (w/v). Hydrolysis of SPI with pepsin was carried out at 37°C and pH of 2.0 using 2 M HCl, and enzyme-substrate ratio of 0.5% (0.5 g enzyme/100 g substrate). The SPI was preincubated for 15 min at 37°C prior to hydrolysis process. The hydrolysis time was set to 4 h. The enzyme was inactivated using heat treatment at 95°C for 15 min in a thermostat-controlled water bath. Afterwards, the sample was cooled on ice to room temperature and centrifuged at 4°C, 12 000 g for 20 min to separate the supernatant from the pellet. Finally, the supernatant (soy protein hydrolysate) was freeze-dried and stored at À20°C (Fig. S1 ).
Preparation of nondigestible soy protein and its hydrolysates
Prior to the in vitro fermentation, samples were enzymatically digested mimicking the upper gut (mouth, stomach and the small intestine). This was accomplished by separately mixing 30 g of soy protein hydrolysate prepared with pepsin (SPH); commercial SPH (SPHcom); and soy protein isolate (SPI), with 500 mL pepsin solution (0.462% pepsin, 49 mM NaCl, 12 mM KCl, 10 mM CaCl 2 , 2.4 mM MgCl 2 , and 2.5 mM K 2 HPO 4 ). The method of Jensen et al. (2009) was followed with slight modifications. The pH was adjusted to 5.5, 3.8 and 1.5 with corresponding incubation periods of 30, 30 and 120 min, respectively. The digestive incubation was performed at 37°C, while stirring at 220 r.p.m. This simulated oral and gastric digestion. Afterwards, 300 mL of bile extract and pancreatin solution (1.25 g of bile extract, 0.2 g of pancreatin, 0.1 M NaHCO 3 dissolved in 50 mL distilled water) was added to the mixture, with the pH adjusted to 5.0, and later to 6.5 for 30 and 240 min, respectively in order to simulate small intestine digestion. The reaction was finally terminated by heating at 95°C for 10 min and cooled to room temperature in ice bath. Nondigestible soy protein and its hydrolysates were removed with 1 KDa MWCO dialysis bag (Spectrum Laboratories, Inc., Rancho Dominguez, CA, USA) with continuous changing of the distilled water permeate, until equilibrium point of solution was attained for up to 72 h. The retentates were lyophilised and stored at À20°C in preparation for batch fermentation study. The protocol has been described in Fig. S2 .
Preparation of faecal slurry
Fresh faeces were collected from four healthy male and female human volunteers who usually ingested a normal diet, presented no digestive tract disease and had not received probiotics, prebiotics or antibiotics for at least 3 months. Freshly passed faeces were immediately taken in an anaerobic chamber, pooled and homogenised with 10% (w/v) of the faecal material in 0.1 M phosphate-buffered saline (PBS), pH 7.0. The slurry was filtered through a 1-mm sieve and used immediately as inoculum.
In vitro pH-controlled, batch culture fermentation Batch fermentation was carried out in water-jacketed fermenters, which were filled with 450 mL of presterilised basal growth medium (consisting of 0.9 g of peptone water, 0.9 g of yeast extract, 0.045 g of NaCl, 0.018 g of K 2 HPO 4 , 0.018 g of KH 2 PO 4 , 0.0045 g of MgSO 4 .7H 2 O, 0.0045 g of CaCl 2 .6H 2 O, 0.9 g of NaHCO 3 , 0.225 g of L-cysteine.HCl, 0.225 g of bile salts, 0.9 mL of Tween-80, 4.5 lL of vitamin K, 0.0225 g of haemin, and 0.45 lL of resazurin at pH 7.0) and inoculated with 10% (v/v) of faecal slurry (Rueangwatcharin & Wichienchot, 2015) . The different samples of soy protein products including SPH, SPHcom and SPI were aseptically added to three vessels to give a final concentration of 1% (w/v). The last vessel served as control (without addition of any sample). The vessels were kept at the temperature of 37°C with a circulating water bath. The contents are magnetically stirred with a maintained pH of 6.8. Oxygenfree nitrogen gas was passed constantly at 15 mL min À1 through the vessels to maintain anaerobic conditions. Samples (5 mL) were taken from each vessel at 0, 6, 12, 24, 48 and 72 h of incubation for SCFAs, BCFAs and microbial population analyses.
Enumeration of bacteria by fluorescent in situ hybridisation (FISH)
Bacterial composition differences were assessed using FISH with oligonucleotide probes designed to target specific diagnostic regions of 16S rRNA based on the method of Wichienchot et al. (2017) . Five different commercially available probes (Bif 164, Lab 158, Bac 303, Chis 150 and Eub 338) labelled with the fluorescent dye Cy3 (Sigma-Aldrich, UK) were used for the different bacterial groups as shown in Table S1 .
Sample ferments (375 lL) taken from each vessel at varying fermentation time were fixed for 4 h at 4°C in 1125 lL 4% (w/v) paraformaldehyde. Fixed cells were centrifuged at 17 000 g for 5 min and washed twice in 1 mL filtered sterile PBS. The washed cells were resuspended in 150 lL filtered PBS and stored in 150 lL ethanol (95%) at À20°C until further use. The samples were optimally diluted in suitable volumes of PBS, and 20 lL of each dilution was added to each well of a six-well PTFE/poly-L-lysine coated slide (Tekdon Inc., Myakka City, USA). The samples were dried for 15 min in a drying chamber (46-50°C). For cells targeted with Lab 158 probe, the protocol was a bit modified to enhance cell permeability. Samples were treated with 20 lL of lysozyme at room temperature for 15 min before washing briefly in cool water. Afterwards, slides were dehydrated using alcohol series (50%, 80% and 96% v/v ethanol) for 3 min in each solution and were returned to the drying chamber for 2 min to evaporate excess ethanol before adding the hybridisation buffer to each well. Hybridisation was carried out for 4 h in a hybridisation oven (GrantBoekel, Cambridge, UK). After hybridisation, slides were washed in prewarmed wash buffer (50 mL) for 15 min, and thereafter dipped in cold water for 3 s. The slides were dried with compressed air, and 5 lL of antifade mix was added onto each well before mounting cover slips on the slides. Slides were examined by epifluorescence microscopy (Eclipse 400, Nikon, Surrey, UK) using the Fluor 100 lens. For each well, 15 fields with a maximum of 300 cells were counted (Wichienchot et al., 2016 (Wichienchot et al., , 2017 . High-performance liquid chromatography analyses of SCFA and BCFA Aliquots (1.5 mL) of samples (0, 6, 12, 24, 48 and 72 h) were centrifuged (13 000 r.p.m. 10 min at 4°C) and filtered through a 0.22-lm membrane filter (Millipore, USA). They were stored at À20°C for SCFAs and BCFAs analyses. Samples were assessed for the SCFAs (lactic, acetic, propionic and butyric acids), as well as the BCFAs (isovaleric and isobutyric acids) using a HPLC apparatus (Agilent model 1200 series, CA, USA). The run was based on calibration curves previously prepared with appropriate chromatographic standards; Aminex HPX-87H ion exclusion column, 300 mm 9 7.8 mm from Bio-Rad (Richmond CA, USA) was used for separation; the eluent was pumped at 0.6 mL min À1 and consisted of 0.005 M H 2 SO 4 mobile phase; and detection was by UV absorbance at 210 nm. The amount of each SCFA and BCFA was calculated based on the peak area with standard curve for quantitative analysis (Wichienchot et al., 2010) .
Statistical analysis
All statistical analyses for bacterial counts, SCFAs and BCFAs were performed using SPSS software, version 17.0. Data are expressed as the mean AE standard deviation (SD) and are the average of triplicate experiments. The level of statistical significance, using analysis of variance (ANOVA) with Tukey's test, was set to P < 0.05.
Results and discussion
Modulation of gut microbiota by nondigestible soy protein and its hydrolysates
Upper gut digestion was simulated for each substrate before moving onto in vitro fermentations in order to obtain nondigestible substrates that have resisted upper gut digestion. As shown in Fig. 1 , all bacteria profiles at time 0 h were very similar, making it possible to serve as baseline from which changes over time caused by fermentable substrates were measured. Some bacterial groups increased significantly (P < 0.05) in the vessels over time, such as the lactobacilli and clostridia groups, while bifidobacteria group tended to decrease significantly (P < 0.05) after the first 12 h, possibly due to substrate type and concentration available. Bacteroides group had a general significant increase (P < 0.05) at 6 h and then decreased dramatically.
The human colon is characterised with diverse bacterial communities (Gull on et al., 2014), playing complex important roles in health and disease. Although the main source of energy for the gut microbiota is carbohydrate fermentation; however, microorganisms switch to other sources when colonic carbohydrate is depleted or not available (Tuohy et al., 2012). These other sources may include proteins and amino acids, whose fermentation products can include SCFAs and BCFAs. SPH and SPHcom proved to be more bifidogenic in the experiment than isolated soy protein. There was a significant increase (P < 0.05) in the population of the bifidobacteria group after the first 12 h of fermentation for the SPH and SPHcom substrates (log 9.97 to log 10.04 and log 9.91 to log 10.04, respectively) compared to SPI (log 9.93 to log 9.91), and the control (log 9.98 to log 9.97). However, SPHcom later decreased gradually (P < 0.05) over time (Fig. 1b) . Bifidobacterium species are known to be greatly beneficial to human gut health by inhibiting pathogen growth, stimulating the immune system and vitamin B complex production (Hidalgo et al., 2012) . Recent studies (Bergillos-Meca et al., 2015; Sirisena et al., 2018) have demonstrated as well that some other compounds (e.g. anthocyanins, flavanols, proteins and lipids) can promote the growth of bifidobacterial and lactobacilli, other than carbohydrates during colonic fermentation. Interestingly, SPH displayed quite a significant increase (P < 0.05) in lactobacilli population across the 72-h timeline (log 9.61 to log 9.84) against both SPI (log 9.50 to log 9.74) and the control (log 9.55 to log 9.70), while SPHcom followed the order, although not stably (log 9.61 to log 9.71) (Fig. 1c) . All these disparities attest that microbiota in the human large intestine act in the most intricate and complex manner; and the increasing bacterial populations showed the pH-controlled fermentation systems were well maintained. The populations of bacteroides decreased (P < 0.05) from the first 6 h until 72 h of fermentation in all substrates studied, which is concurrent with positive influence as far as bacteroides modulation is concerned on gut health. This is in perfect harmony with previous observation that bacteroides group cannot replace ammonia with other nitrogen sources such as amino acids, peptides, urea or nitrate (Sanz et al., 2005) , but has a wide range of substrate utilisation. On the other hand, all substrates also induced higher (P < 0.05) clostridia populations across the experimental timeline, with SPHcom obtaining the highest (P < 0.05) level (log 9.82). The clostridia group, which is strictly anaerobic, has detrimental effect on colon health. An increase in clostridial population may not result directly from the substrates used, but due to fermentation conditions. However, soy protein and both of its hydrolysates used in this experiment showed varying numbers of the group in higher numbers than the control. In addition, proteolytic bacteria including some members of bacilli, pseudomonas and clostridia genera thrive on substrates that are rich in proteins.
Gut microbial balance indices of nondigestible soy protein and its hydrolysates
The highest GMBI values (P < 0.05) obtained in this study were found in SPH (0.23) as compared to SPI and SPHcom (0.23 and 0.22, respectively) after 24-h fermentation. This is shown in Fig. 2 . All substrates observed within the fermentation timeline actually had positive microbial balance indices. However, the values are much lower (P < 0.05) than other works reported, possibly due to prebiotic substrates used. Those PI (equivalent GMBI) values include 6.90 and 6.12 for bergamot peel and fructo-oligosaccharides (FOS), respectively (Vardakou et al., 2008) . More importantly, the increase in GMBI values at varying time intervals, especially at 24 h, in the reports were in accord with this work. There was a minimal decrease (P < 0.05) of the score for SPH after 24 h, but was later increased after 72 h. This disparity between SPH and the other substrates (SPI and SPHcom) is obviously due to their different compositions and molecular size of protein. The gut microbial balance index (GMBI) refers to the positive or negative correlations between the growth of beneficial bacteria (e.g. bifidobacteria and lactobacilli) and harmful or 'undesirable' ones (e.g. clostridia and bacteroides), while relating them to the changes in total bacterial population (eubacteria) (Vardakou et al., 2008) . Investigating the gut microbial balance of bioactive compounds by in vitro fermentation with human faecal microbiota provides a cost-effective and rapid option to 
Production of SCFAs and BCFAs by nondigestible soy protein and its hydrolysates
The concentrations of lactic, acetic, propionic and butyric acids produced during 72-h fermentation timeline is shown in Being an important metabolite of bifidobacteria, acetate is quite useful for muscle and tissue functioning, while propionate and butyrate are equally important for liver and colonic mucosa functions, respectively (Furusawa et al., 2013) . As quantity amounts of butyrate were accumulated in the substrates fermented (24.04 AE 0.14 and 20.32 AE 0.45 mM for SPH after 72 h, and SPHcom after 48 h, respectively), it might be due to the increased population of the clostridia group. Apart from the clostridia cluster, certain members of eubacteria and faecalibacteria are among other butyrate-producing bacteria. Butyrate releases immense energy into the colon system by regulating cell differentiation and modulating the transcription of numerous genes associated with mucin and hormone production (Macfarlane & Macfarlane, 2003) . Substrate's type or amount obviously affected the composition of the intestinal microbiota and consequently the type and amount of SCFAs produced. Over the experimental time intervals, all substrates induced increased amounts of acetate, propionate and butyrate, except lactate. Lactate is primarily produced by lactobacilli, and its volatility in the colon may be attributed to fermentative ability of some other bacterial species in a cross-feeding mechanism. Several factors including type of protein degraded and available concentrations of nondigestible protein that reach the colon are responsible for the relative amounts of SCFAs and BCFAs. SCFAs provide useful information on the gut microbial population due to inhibition of pathogen growth by increasing acidity in the lumen. In addition, propionate and acetate are partially oxidised in the colonocytes, travel through the portal vein to the liver and serve as substrates for gluconeogenesis and lipogenesis (Tremaroli & B€ ackhed, 2012) .
Production of BCFA is shown in Table 2 . In contrast to other reports which used substrates other than pure protein or protein products (Blatchford et al., 2015; Rodrigues et al., 2016) , much higher amounts of BCFAs were recorded in this study. SPHcom appeared to consist of additional (proteinaceous) compounds due to its high (P < 0.05) yield of total BCFAs (616.74 mM) after 72-h fermentation in vitro, compared to the control (142.75 mM), or the main substrate under evaluation, that is SPH (481.13 mM). SPI substrate only stimulated its highest (P < 0.05) total BCFAs production after the first 12 h of fermentation (151.62 mM). However, SPHcom, SPH and SPI substrates in our The highest isobutyrate and isovalerate levels in seaweed and mushroom extracts obtained were of 2.6 and 2.0 mM, respectively (Rodrigues et al., 2016) , whereas a much lesser amounts of BCFAs (≤0.002 mM isobutyrate and ≤0.007 mM isovalerate) was obtained in kiwifruit (Blatchford et al., 2015) . This is because carbohydrate fermentation produces large amounts of SCFA and low amounts of BCFA in contrast with protein, as shown in this study. When branched chain amino acids such as leucine, isoleucine and valine are fermented, BCFAs are produced, mainly isobutyrate and isovalerate (Macfarlane & Macfarlane, 2003) . Usually, low amounts of protein escape upper gut digestion before reaching the colon, even though few amounts of protein and its hydrolysates would have much impact on colonic fermentation as shown in this study. BCFAs play paramount roles in the nervous system by transmitting neural signals (Kotani et al., 2009) , apart from maintaining balance in the secretion and regulation of electrolyte absorption. As information on metabolism and effects of branched-chain fatty acid in the large intestine is scanty, further work is recommended in this regard.
Conclusion
All the substrates investigated modulated human gut microflora in vitro, to some extents. SPH did not support the growth of bacteroides population, but could not hamper that of clostridia. It, however, induced the growth of lactobacilli but not bifidobacteria group. This selective increase is consistent with increase in total SCFA produced by SPH. The commercial SPH (SPHcom) gave higher yields of BCFAs when compared to the SPH, or even isolated protein (SPI). In general conclusion, colonic fermentation of SPI and its hydrolysates had affected proteolytic bacteria and produced high amounts of BCFA than SCFA.
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